Skip to main content
. Author manuscript; available in PMC: 2017 Mar 15.
Published in final edited form as: Biochem Pharmacol. 2016 Feb 18;104:131–138. doi: 10.1016/j.bcp.2016.02.009

Table 1.

Summary of activity of hPXR WT and mutants in HepG2 cells (CYP3A4 promoter activity; see Figures 1, 2A and 4 for details).

Type of substituting residue(s) WT hPXR or hPXR mutants RIF activity SR activity TO activity
None hPXR +++ +++ +++
Hydrophobic W299A +++ +++ +
W299V +++ not tested not tested
Charged W299D +/− +/− +/−
W299E +/− +/− +/−
W299K +/− +/− +/−
Double mutants W299A-F288A +++ +/− +/−
W299D-F288A +/− +/− +/−
Triple mutant W299A-F288A-Y306A

+++ strongly active;

+ weakly active;

+/− very weak or inactive;

− complete loss of function